This content is machine translated Urothelial carcinoma of the urinary bladder A challenge even in times of immune checkpoint inhibitors Urothelial carcinoma accounts for 90% of urinary bladder tumors. Every year, 1250 people in Switzerland contract the disease – predominantly older men. Standard treatment is cisplatin-containing chemotherapy. Immunotherapy is playing…
